In Reply

JAMA

Volumn 301, Issue 13, 2009, Pages 1338-

  Thombs, Brett D ^a   De Jonge, Peter ^b   Ziegelstein, Roy C ^c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; DEPRESSION; HEALTH SERVICE; HEART DISEASE; HUMAN; LETTER; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SCREENING TEST;

EID: 63849260786     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.409     Document Type: Letter

References (6)

1. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al; American Heart Association Prevention Committee of the Council on Cardiovascular Nursing; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention; American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research; American Psychiatric Association. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation. 2008;118(17):1768-1775.
2. Barratt A, Irwig L, Glasziou P, et al; Evidence-Based Medicine Working Group. Users' guides to the medical literature: XVII, how to use guidelines and recommendations about screening. JAMA. 1999;281(21):2029-2034.
3. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet. 2002; 359(9309):881-884.
4. Mant D, Fowler G. Mass screening: theory and ethics. BMJ. 1990;300(6729): 916-918.
5. Gartlehner G, Gaynes BN, Hansen RA, et al. Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Ann Intern Med. 2008;149(10):734-750.
6. Patten SB. A framework for describing the impact of antidepressant medications on population health status. Pharmacoepidemiol Drug Saf. 2002;11(7):549-559.